Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer

NCT00416494 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: oxaliplatin
DRUG: Capecitabine
DRUG: Capecitabine

Sponsor

Herbert Hurwitz, MD

Collaborators

[object Object]